Unique Cohorts of Salivary Gland Cancer Cells as an in-vitro Model of Circulating Tumor Cells
- PMID: 39118911
- PMCID: PMC11303642
- DOI: 10.1007/s12663-024-02250-0
Unique Cohorts of Salivary Gland Cancer Cells as an in-vitro Model of Circulating Tumor Cells
Abstract
Introduction: The characterization of circulating tumor cells (CTC) and circulating tumor microemboli (CTM) has emerged as both a challenge to the standard view of metastasis, and as a valuable means for understanding genotypic and phenotypic variability shown even within the same cancer type. However, in the case of salivary gland neoplasms, limited data are available for the role that CTCs and CTMs play in metastasis and secondary tumor formation.ru.AQ1 In response to this, we propose that similarities between in vitro clusters of cultured salivary gland cancer cells may act as a surrogate model for in vivo CTCs and CTMs isolated from patients.
Materials and methods: Using techniques in immunofluorescence, immunoblotting, and 2-dimensional migration, we isolated and characterized a group of cohort cells from a commercially available cell line (HTB-41). Results: Here, cells exhibited a hybrid phenotype with simultaneous expression of both epithelial and mesenchymal markers (E-cadherin, vimentin, and α-SMA). Cohort cells also exhibited increased migration in comparison to parental cells.
Conclusion: Data suggest that these isolated cell clusters may fucntion as a potential in vitro model of CTCs and CTMs.
Keywords: Circulating tumor cells; Circulating tumor microemboli; E-cadherin; Epithelial to mesenchymal transition; Metastasis; Salivary gland cancer; Vimentin; α-SMA; β- catenin.
© The Association of Oral and Maxillofacial Surgeons of India 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Similar articles
-
CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor.Int J Mol Sci. 2023 Jul 26;24(15):11958. doi: 10.3390/ijms241511958. Int J Mol Sci. 2023. PMID: 37569332 Free PMC article.
-
Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer.Transl Cancer Res. 2022 Aug;11(8):2636-2646. doi: 10.21037/tcr-22-529. Transl Cancer Res. 2022. PMID: 36093536 Free PMC article.
-
Associations between the Epithelial-Mesenchymal Transition Phenotypes of Circulating Tumor Cells and the Clinicopathological Features of Patients with Colorectal Cancer.Dis Markers. 2017;2017:9474532. doi: 10.1155/2017/9474532. Epub 2017 Dec 21. Dis Markers. 2017. PMID: 29430076 Free PMC article.
-
Circulating tumor microemboli: Progress in molecular understanding and enrichment technologies.Biotechnol Adv. 2018 Jul-Aug;36(4):1367-1389. doi: 10.1016/j.biotechadv.2018.05.002. Epub 2018 May 18. Biotechnol Adv. 2018. PMID: 29753882 Review.
-
Mesenchymal Characteristics and Predictive Biomarkers on Circulating Tumor Cells for Therapeutic Strategy.Cancers (Basel). 2020 Nov 30;12(12):3588. doi: 10.3390/cancers12123588. Cancers (Basel). 2020. PMID: 33266262 Free PMC article. Review.
References
-
- Barnes L, Eveson J, Reichart P et al (2005) World health organization classification of tumours: pathology and genetics of head and neck tumours. IARC Press, Lyon